Concepedia

Publication | Closed Access

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours

DOI

14

Citations

4

References

2003

Year

Ahmad Awada, R. Thödtmann, Martine Piccart, J. Wanders, A. H. G. J. Schrijvers, I.-M. von Broen, Axel‐R. Hanauske
European Journal of Cancer

References

YearCitations

Page 1